Onconova Therapeutics- Warrants (01/08/2021) Profit Margin

The latest profit margin for ONTXW is 328309.64% as of June 2026. That compares with -9559.29% in the prior-year period — up 3534.5% year over year. That is above the Healthcare sector average of 19.13%. Investors often review this figure alongside Onconova Therapeutics- Warrants (01/08/2021)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ONTXW's profit margin moved from -9559.29% to 328309.64% — a 3534.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Onconova Therapeutics- Warrants (01/08/2021)'s valuation or profitability profile.

Against Healthcare companies, ONTXW currently prints 328309.64% for profit margin, while the sector average sits near 19.13%. That is roughly 1715986.4% above the sector mean. Large gaps often invite a closer look at Onconova Therapeutics- Warrants (01/08/2021)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Onconova Therapeutics- Warrants (01/08/2021) converts resources into returns. At 328309.64%, ONTXW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -9559.29% in the prior-year period — up 3534.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ONTXW's profit margin (328309.64%), review year-over-year change from -9559.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.